Growth Metrics

Omnicell (OMCL) Other Operating Expenses (2010 - 2022)

Omnicell (OMCL) reported Other Operating Expenses of -$3.5 million for Q1 2022, down 75.0% year-over-year from -$14.0 million in Q1 2021, and down 75.0% on a QoQ basis from -$2.0 million in Q1 2021.

Omnicell (OMCL) has 4 years of Other Operating Expenses data on file, last reported at -$3.5 million in Q1 2022.

  • Quarterly Other Operating Expenses fell 75.0% year-over-year to -$3.5 million in Q1 2022, while the trailing twelve-month figure through Dec 2022 was -$3.5 million (down 75.0% YoY) and the FY2015 annual result came in at -$3.4 million, changed N/A from the prior year.
  • Other Operating Expenses retreated to -$3.5 million in Q1 2022 per OMCL's latest filing, from -$2.0 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at -$2.0 million in Q1 2021 and bottomed at -$3.5 million in Q1 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn
10 Teladoc Health 1.42 Bn 672.39 Mn 562.57 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2022 -3.50 Mn
Mar 31, 2021 -2.00 Mn
Jun 30, 2015 -3.44 Mn
Sep 30, 2010 -43,000.00